Romano Brothers AND Company Trims Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Romano Brothers AND Company cut its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 18.2% in the fourth quarter, HoldingsChannel reports. The firm owned 17,154 shares of the pharmacy operator’s stock after selling 3,821 shares during the period. Romano Brothers AND Company’s holdings in Walgreens Boots Alliance were worth $160,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. First Financial Corp IN raised its stake in shares of Walgreens Boots Alliance by 49.2% in the fourth quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock worth $25,000 after purchasing an additional 885 shares during the last quarter. Strategic Investment Solutions Inc. IL acquired a new stake in Walgreens Boots Alliance during the 2nd quarter worth $34,000. TD Private Client Wealth LLC grew its position in shares of Walgreens Boots Alliance by 8,670.3% in the third quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock valued at $29,000 after purchasing an additional 3,208 shares in the last quarter. Sentry Investment Management LLC acquired a new stake in Walgreens Boots Alliance during the third quarter worth about $30,000. Finally, Eastern Bank purchased a new position in shares of Walgreens Boots Alliance during the 3rd quarter worth $33,000. Institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Trading Down 3.2 %

Shares of NASDAQ WBA opened at $12.52 on Monday. Walgreens Boots Alliance, Inc. has a 52 week low of $8.08 and a 52 week high of $23.76. The business has a 50 day simple moving average of $9.57 and a 200 day simple moving average of $9.84. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.37 and a current ratio of 0.68. The stock has a market cap of $10.81 billion, a price-to-earnings ratio of -1.22, a PEG ratio of 1.55 and a beta of 0.64.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last issued its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, topping the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The company had revenue of $39.50 billion for the quarter, compared to the consensus estimate of $37.40 billion. During the same period in the previous year, the business posted $0.66 EPS. The company’s revenue for the quarter was up 7.6% on a year-over-year basis. On average, research analysts predict that Walgreens Boots Alliance, Inc. will post 1.52 earnings per share for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, December 12th. Stockholders of record on Monday, November 18th were paid a $0.25 dividend. The ex-dividend date of this dividend was Monday, November 18th. This represents a $1.00 annualized dividend and a dividend yield of 7.99%. Walgreens Boots Alliance’s dividend payout ratio is presently -9.77%.

Analyst Ratings Changes

Several research analysts have recently commented on WBA shares. Jefferies Financial Group lowered their price target on Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a research report on Wednesday, October 23rd. Truist Financial increased their price objective on shares of Walgreens Boots Alliance from $10.00 to $13.00 and gave the company a “hold” rating in a research report on Thursday. UBS Group raised their target price on Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a “neutral” rating in a research report on Thursday, October 17th. Barclays boosted their price objective on Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an “underweight” rating in a research note on Wednesday, October 16th. Finally, Royal Bank of Canada lifted their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a research report on Wednesday, January 15th. Four research analysts have rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $13.27.

View Our Latest Analysis on WBA

About Walgreens Boots Alliance

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Recommended Stories

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.